Cellestia is a clinical-stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus.

Pharmaceutical

Cellestia Biotech

Cellestia Biotech's headquarters in Basel, Switzerland

Rajwinder Lehal

Maria Bobadilla

Marc Lang

Richard Herrmann

Robert Karsunky

Alfredo Covelli

Jon Aster

Rhett Kovall

Renata Ferrarotto

Guido Guidi

Douglas Hanahan

Silvio Inderbitzin

Karen Chu

The Advisory Team at Cellestia Biotech provides strategic guidance and expertise to support the development of innovative therapies. Comprised of industry experts, this team advises on clinical strategy, regulatory pathways, and potential market opportunities to ensure the successful advancement of Cellestia's R&D efforts.

Advisory Team

The Leadership Team at Cellestia Biotech oversees the strategic direction and operational management of the company. Comprising key executives like the CEO and Chief Financial Officer, they drive decision-making processes, manage resources, and foster collaborations to advance the development of groundbreaking therapies targeting pathogenic gene expression. Their focus is on ensuring alignment with the company’s mission and navigating the complexities of the clinical-stage biotech landscape.

Leadership Team

Cellestia Biotech

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Cellestia Biotech

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies